Connect with us

Health

Artificial Intelligence Makes Pharmaceutical Research Less Expensive—NAPHARM Boss

Published

on

NAPHARM pharmaceutical research

By Modupe Gbadeyanka

The President of the Nigeria Academy of Pharmacy (NAPHARM), Mr Julius Adelusi-Adeluyi, has charged Nigerian pharmacists to begin to explore the use of artificial intelligence for pharmaceutical research and new drug discovery.

Speaking at the investiture of new fellows of the academy in Lagos on December 8, 2022, the pharmacist also disclosed that AI makes pharmaceutical research less expensive and more productive.

He explained that, “Researchers realize that in the time that it would have taken to test the efficacy of, say, a handful of chemical molecules manually, with AI, it is possible to test several hundreds of different chemical molecules.

“With AI, therefore, we can create better, safer and more affordable medicines within a much shorter time frame too.

“In addition to helping to ensure that basic facilities, including clean water and electricity, are available, government policy direction must also be such that deliberately enables AI to take root and grow.”

Mr Adelusi-Adeluyi lauded the progress being made globally in the areas of big data, artificial intelligence and machine Learning, calling on the government to help create the right environment that makes meaningful research possible.

The NAPHARM boss, who is a former Minister of Health, also emphasized the need for Nigeria to commit to producing active manufacturing ingredients (API) for drugs manufacturing, given the vast hydrocarbon resources that it is endowed with, rather than continued reliance on the importation of same raw materials, encouraging pharmacists in the country to engage the nation’s political leadership on the issue.

“Pharmacists need to enlighten the political leadership, including today’s presidential aspirants, on this issue and painstakingly interrogate them on their plans for utilizing Nigeria’s oil and gas deposits.

“The political leadership needs to better appreciate why a petrochemical industry is critical to Nigeria, and pharmacists have a role not only to continue to drive this enlightenment but also participate actively in the electoral process,” he said.

Speaking on reforms in the health sector, while presenting a paper titled Advancing Pharmacy for Economy Prosperity Nigeria, the President of the Pharmaceutical Society of Nigeria (PSN), Professor Cyril Usifoh, kicked against the step being taken to make the National Agency for Food and Drug Administration and Control (NAFDAC) a revenue-generating agency, noting that it would make the prices of drugs and medicines to soar.

Professor Usifoh commended the increased participation of pharmacists in Nigerian politics, extolling the academy and pharmacists for their dedication towards ensuring the safety of lives of the citizenry and urged them to continue doing their best to reposition the pharmacy profession in the country.

Speaking on behalf of the newly inducted members, Mr Sadiq Umar said that the inductees, who were drawn from different spheres of endeavour, have particular responsibilities towards the academy and the pharmacy profession and urged the organisation to do the best they can to reposition the profession.

Business Post reports that 20 leading pharmacists were inducted into the academy, including the Deputy Vice-Chancellor (Academics) of the University of Benin, Professor Ray Ozolua; Managing Director of GSK Nigeria, Kunle Oyelana; Managing Director, Medplus Pharmacy Chain, Joke Bakare; Executive Director, the Nett Pharmacy Chain, Chris Ehimen; and Registrar of the Pharmacy Council of Nigeria (PCN), Babashehu Ahmed.

Modupe Gbadeyanka is a fast-rising journalist with Business Post Nigeria. Her passion for journalism is amazing. She is willing to learn more with a view to becoming one of the best pen-pushers in Nigeria. Her role models are the duo of CNN's Richard Quest and Christiane Amanpour.

Continue Reading
1 Comment

Leave a Reply

Health

FG Begins Vaccination Against Mpox in FCT, Six States

Published

on

Monkeypox mpox

By Adedapo Adesanya

The Federal Ministry of Health and Social Welfare through the National Primary Health Care Development Agency (NPHCDA) has commenced the vaccination against Monkeypox, now known as Mpox.

Business Post reports that Bayelsa, Rivers, Cross River, Akwa Ibom, Enugu, Benue, and the Federal Capital Territory, were selected as pilot states for the vaccination.

An average of 631 persons are expected to be vaccinated across the seven states with two doses of the Mpox vaccine. A buffer for 50 persons will be kept at the national in case of an upsurge in other states.

NPHCDA in a statement posted on its verified X account confirmed the exercise, stressing that the vaccination will help to protect communities and safeguarding health of the people.

In a related development, according to the latest update by the Nigeria Centre for Disease Control (NCDC), there are 1,442 suspected cases of Mpox from 36 states and the Federal Capital Territory, while the number of confirmed cases of the infection was 118 from 28 states and the FCT.

“To prevent the spread of Mpox, we strongly advise the public to avoid contact with animals that may carry the virus, including sick or dead animals in affected areas, avoid handling materials that have been in contact with infected animals, limit unnecessary physical contact with individuals who are infected, practice frequent handwashing with soap and water, and ensure that animal food products are thoroughly cooked before eating.

“It’s also important to use protective clothing and gloves when handling sick animals or their tissues. Similarly, health workers are advised to follow standard safety protocols including droplet precautions when treating patients, use protective equipment including masks, gloves, and gowns, during patient care, and be vigilant for symptoms of Mpox, especially fever and rash, among other measures.”

Continue Reading

Health

AXA Mansard Health Partners LUTH in Blood Donation Drive

Published

on

Axa Mansard

By Aduragbemi Omiyale

Over 250 pints of blood have been donated by AXA Mansard Health to the Lagos University Teaching Hospital (LUTH), Idi Araba.

The blood was donated by more than 100 employees of the leading health insurance company in Nigeria through its volunteering programme tagged AXA Hearts in Action.

The initiative is part of the company’s blood donation drive aimed at contributing to positive societal and environmental impacts through employee volunteering, and expertise related financial support and in-kind donations.

According to the Chief Client Officer of AXA Mansard, Ms Rashidat Adebisi, “Through the AHIA, our employees do not just give time to great causes; we work together for a better future.”

“We share our time, knowledge and expertise as a people with a shared purpose of acting for human progress by protecting what matters through initiatives like this,” she added.

Ms Adebisi said the blood drive is a shining example of the philosophy in action, where collective contributions serve as a reminder that true impact often involves giving more than just money. It’s about putting one’s heart in action – an idea embedded in AXA’s corporate culture.

On his part, the chief executive of AXA Mansard Health Limited, Mr Tope Adeniyi, said with hospitals frequently experiencing blood shortages, events like these serve as a lifeline for patients in need.

“We are proud to contribute to the local healthcare sector and provide much-needed support to hospitals such as LUTH, ensuring that they have resources essential to saving lives,” he added.

Also commenting, the Head of Corporate Services and Public Relations at LUTH, Omolola Olubukunola Fakeye, thanked the firm for the “generous support,” which has made a “meaningful difference to our blood bank and ultimately to the lives of patients.”

“Blood donations are invaluable in many critical treatments, and initiatives like AXA Mansard’s blood drive bring immense relief to healthcare system.

“We are sincerely grateful for this partnership and the dedication of AXA Mansard’s employees,” Fakeye stated.

AXA Hearts in Action operates globally, she urging AXA employees everywhere to engage with and give back to their communities.

Through diverse projects – from health initiatives like this blood drive and medical outreaches to environmental efforts like the AXA Week for Good “Trash-to-Treasure” waste management project – AXA staff have opportunities to make a lasting difference on issues that matter.

For AXA Mansard, every act of social service brings them closer to the communities they serve, helping build a world where giving back is not only about charity but about lasting, positive change.

Continue Reading

Health

US Buys 4.8 million Swipha Malaria Doses for Nigeria, Others

Published

on

Swipha

By Adedapo Adesanya

The US Agency for International Development (USAID) has committed $2.3 million to procure 4.8 million doses of life-saving malaria tablets from Swiss Pharma (Swipha) in a landmark partnership that will expand access to essential medicines in Nigeria and West Africa.

This procurement, to be facilitated through the U.S. Government’s President’s Malaria Initiative (PMI), underscores the United States’ dedication to advancing Nigeria’s healthcare infrastructure and ensuring life-saving treatments reach vulnerable communities.

For years, Nigeria has faced significant challenges in procuring affordable, high-quality medicines due to the high cost of production and the inability of many local pharmaceutical companies to meet international quality standards.

According to the World Health Organization (WHO), fewer than 10 per cent of medicines manufactured in sub-Saharan Africa meet global standards, limiting local companies’ ability to supply essential drugs and meet healthcare needs.

These barriers have particularly affected access to medicines for malaria and child health, as local production has often fallen short of both quality and quantity requirements.

In response, USAID partnered with Swipha in their efforts to attain World Health Organization (WHO) prequalification for sulfadoxine/pyrimethamine (SP) tablets, a vital medicine for malaria prevention during pregnancy.

Swipha is now the first pharmaceutical company in Nigeria and in West Africa to achieve this WHO certification, marking a critical step forward for the region’s pharmaceutical capacity.

“USAID’s support was pivotal in helping us reach this milestone,” said Swipha Managing Director, Mr Frederic Lieutaud.

“The WHO prequalification not only validates our commitment to producing high-quality medicines but also enhances our capacity to scale production and serve both local and international markets with trusted, essential medicines.”

With the WHO prequalification, Swipha is well-positioned to expand its reach, supplying these essential medicines to international donors and procurement agencies, ultimately strengthening healthcare delivery across Nigeria and the broader West African region.

This achievement also represents a significant boost to Nigeria’s healthcare system by enhancing local manufacturing capacity and contributing to public health efforts to combat preventable diseases.

During her visit to Swipha’s facility in Lagos, USAID Mission Director to Nigeria, Ms Melissa Jones, commented “This achievement is a testament to the power of collaboration in improving healthcare in Nigeria.

“We are proud to have supported Swipha in reaching this milestone and look forward to continuing our partnership to ensure more quality medicines reach those who need them most. Together, we are building a healthier future for Nigeria.”

Continue Reading

Trending